Select Vaccines chief banned from corporate world for 10 years; GSK, AZ could face tough year;

 @FierceBiotech: Biotechs tackle new frontiers in vaccine production. Report | Follow @FierceBiotech 

 @JohnCFierce: It looks like just about every biotech out there wants a piece of the new $1B federal tax credit/grant. Report | Follow @JohnCFierce

> Dr. Martin Soust, a former chief executive of Select Vaccines, will pay an $80,000 penalty and be banned from the corporate world for 10 years for buying shares in his listed biotech company to push the share price higher. Report

> Britain's leading drugmakers, GlaxoSmithKline and AstraZeneca, should report healthy quarterly results next week, helped by swine flu and other one-offs--but the rest of the year will be more tricky. News

> A new vaccine against Alzheimer's, developed by the Austrian biotechnology firm Affiris, will soon be tested in six European countries, the company announced Friday. Story

> The City of Chandler has signed an 11-year lease for 38,146 square feet at San Tan Tech Center for a biotechnology incubator site. Story

> Cellsafe International Group, a regional stem cell biotechnology company, is to expand its biotechnology business and research and development activities in Indonesia following a strategic partnership with PT Kimia Farma TBK (Kimia Farma). Item

> Urigen Pharmaceuticals, a specialty pharmaceutical company focused on the development of treatments for urological disorders and pain, announced today that it has filed a request for an FDA meeting to advance the URG101 clinical program and mutually agreed with Oceana Therapeutics to terminate their Consulting Agreement effective immediately. Release

> Oncolytics Biotech announced today that it has completed Phase I patient enrollment in its Phase I/II clinical trial to investigate the use of REOLYSIN for patients with recurrent malignant gliomas (REO 007). The principal investigator is Dr. James Markert, Division Director of Neurosurgery, and Professor, Neurosurgery and Physiology, the University of Alabama at Birmingham. Release

And Finally... Hoping the county will become a biotech hub, the Los Angeles County board of supervisors approved a pilot project to offer free laboratory space in an unused hospital for a biotech incubator. Report

Suggested Articles

Comet Therapeutics unveiled itself with $28.5 million in series A financing and biopharma veteran David De Graaf at the helm.

Frontage is Growing to Meet All Your Needs! Click Here to Learn About the Next Generation of Frontage.

Cara Care, a digital health startup focused on digestive diseases, raised $7 million to bring its mobile app to more patients in the U.S.